Autori: Santoni Matteo
| Naslov | Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study (Article; Early Access) |
| Autori | Santoni Matteo ... Popovic Lazar S ... (broj koautora 43) |
| Info | CANCER IMMUNOLOGY IMMUNOTHERAPY, (2023), vol. br. , str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: |
